Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Difflam Plus Anaesthetic Sore Throat Lozenges |
| Active Ingredients: | Benzydamine hydrochloride 3mg Dichlorobenzyl alcohol 1.2mg Lidocaine hydrochloride 4mg |
| Dosage Form: | Lozenge |
| New Zealand Sponsor: | iNova Pharmaceuticals (New Zealand) Limited |
| Manufacturer: | Unique Pharmaceuticals Laboratories, Nani Daman, India |
| Product: | Idacio (Vial) |
| Active Ingredient: | Adalimumab 50mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Fresenius Kabi New Zealand Limited |
| Manufacturer: | Merck Serono SA, Aubonne, Switzerland |
| Product: | Idacio (Syringe and Pen) |
| Active Ingredient: | Adalimumab 50mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Fresenius Kabi New Zealand Limited |
| Manufacturer: | Merck Serono SpA, Bari, Italy |
Dated this 17th day of July 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).